Scarica l'app Stockscreener
24.75
2.78%
0.67
Pre-mercato:
24.76
0.01
+0.04%
Precedente Chiudi:
$24.08
Aprire:
$24.08
Volume 24 ore:
3.50M
Relative Volume:
0.66
Capitalizzazione di mercato:
$12.30B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
61.88
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
+0.28%
1M Prestazione:
+9.90%
6M Prestazione:
+79.48%
1 anno Prestazione:
+105.74%
Intervallo 1D:
$23.96
$24.77
Intervallo di 1 settimana:
$23.91
$25.03
Portata 52W:
$8.02
$25.29
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
24.75 | 11.96B | 4.45B | 205.00M | 372.00M | 0.40 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.49 | 54.43B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
124.94 | 55.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
10.56 | 46.62B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.52 | 39.10B | 17.39B | 1.43B | 774.28M | 1.219 |
|
UTHR
United Therapeutics Corp
|
475.00 | 20.21B | 3.13B | 1.27B | 1.12B | 26.39 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Hardman Johnston Global Equity Strategy initiated a position in Elanco Animal Health (ELAN) - MSN
Bank of America Securities Sticks to Their Buy Rating for Elanco Animal Health (ELAN) - The Globe and Mail
Mitsubishi UFJ Trust & Banking Corp Takes $1.44 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
UBS Group Forecasts Strong Price Appreciation for Elanco Animal Health (NYSE:ELAN) Stock - MarketBeat
Great Lakes Advisors LLC Takes $9.42 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Mutual of America Capital Management LLC Takes $4.62 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Federated Hermes Inc. Grows Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Retirement Systems of Alabama Invests $12.10 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
INVESTOR ALERT AND NOTICE: Kaskela Law Firm Announces Investigation of Elanco Animal Health Inc. and Encourages Long-Term Elanco Investors with Losses to Contact the FirmELAN - ACCESS Newswire
Hardman Johnston Global Equity Strategy Initiated a Position in Elanco Animal Health (ELAN) - Insider Monkey
A Look At Elanco Animal Health (ELAN) Valuation After Recent Analyst Upgrades And Regulatory Approvals - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Has $6.10 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
How Piper Sandler’s Upgrade and New Vet-Channel Approvals Will Impact Elanco Animal Health (ELAN) Investors - Yahoo Finance
Estate Counselors LLC Makes New $4.24 Million Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat
2 Profitable Stocks to Own for Decades and 1 Facing Headwinds - Finviz
Investment Report: Is Elanco Animal Health Incorporated attractive for institutional investorsWeekly Gains Report & Daily Momentum Trading Reports - baoquankhu1.vn
Around Town: Elanco Animal Health - actionnewsjax.com
Piper Sandler Upgrades Elanco Animal Health (ELAN) to Overweight with $30 Price Target - Intellectia AI
Elanco (ELAN) Upgraded by Piper Sandler Amid Corporate Gains - GuruFocus
Elanco Animal Health stock hits 52-week high at 25.0 USD - Investing.com Canada
Elanco upgraded, Zoetis downgraded at Piper Sandler (ELAN:NYSE) - Seeking Alpha
Piper Sandler upgrades Elanco as co gains traction with veterinary groups - Investing.com Canada
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement - Finviz
Breaking Down Elanco Animal Health: 5 Analysts Share Their Views - Benzinga
Feather in Her Cap Association Announces 2026 Award Winners for Outstanding Achievements in the Animal Health Industry - BlueRidgeNow.com
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Elanco (ELAN) Upgraded by Analyst with Increased Price Target - GuruFocus
Piper Sandler Upgrades Elanco Animal Health (ELAN) and Raises Pr - GuruFocus
This Elanco Animal Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Feline Vaccines Market Overview and Leading Players: Merck & Co, - openPR.com
Elanco Animal Health Incorporated $ELAN Shares Acquired by Amalgamated Bank - MarketBeat
Pet Pharmaceuticals Market Is Booming Worldwide 2026-2033 | Zoetis • Merck Animal Health • Elanco Animal Health - openPR.com
Animal Parasiticides Market with Insights from Boehringer - openPR.com
Animal Health Market Overview and Leading Players: Bayer, Ceva - openPR.com
Elanco Animal Health (NYSE:ELAN) Hits New 1-Year High on Analyst Upgrade - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth Potential Amidst Market Dynamics - DirectorsTalk Interviews
Poultry Antibiotic Market Is Booming Worldwide 2026-2033 - openPR.com
The Glucosamine Supplements for Dogs Market, Global Forecast 2026-2032 | Innovation Drives Canine Glucosamine Supplement Market with New Chewable and Liquid Formats - GlobeNewswire Inc.
Veterinary Vaccines Market to Reach USD 236 Million by 2031 | CAGR - openPR.com
Anticoccidial Drugs Market to Reach USD 2.52 Billion by 2033 | - openPR.com
Elanco Animal Health (NYSE:ELAN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
State of Alaska Department of Revenue Takes Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
New York State Teachers Retirement System Invests $5.50 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
ASR Vermogensbeheer N.V. Trims Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Institution Moves: What is the next catalyst for Elanco Animal Health IncorporatedJuly 2025 Sentiment & Capital Efficient Trading Techniques - baoquankhu1.vn
Nisa Investment Advisors LLC Lowers Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Investor Mood: Can Elanco Animal Health Incorporated reach all time highs this yearTrade Exit Report & AI Optimized Trade Strategies - baoquankhu1.vn
Risk Hedge: Can Elanco Animal Health Incorporated ride the EV wave2025 Biggest Moves & Reliable Entry Point Alerts - baoquankhu1.vn
Elanco Animal Health stock hits 52-week high at 24.51 USD - Investing.com Canada
Oregon Public Employees Retirement Fund Invests $2.01 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):